Engineering the Future: Exploring Market Segmentation and Market Size in the Tissue Engineering Market

The tissue engineering market size has grown rapidly in recent years. It will grow from $13.36 billion in 2023 to $15.38 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%. The growth in the historic period can be attributed to advancements in biomaterials, growing aging population, increasing incidence of chronic diseases, regulatory support for regenerative medicine, rising patient demand for organ transplants.

The tissue engineering market size is expected to see rapid growth in the next few years. It will grow to $26.33 billion in 2028 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to precision medicine approaches, increasing focus on immunomodulation, expanding applications in orthopedics, increased funding and investment, rising prevalence of chronic diseases. Major trends in the forecast period include integration of nanotechnology, 3d cell culture techniques, development of organ-on-a-chip technology, artificial intelligence integration,innovative cell sources.

Market Overview -
Tissue engineering refers to the biomedical engineering discipline that involves integrated techniques from biology and engineering to produce 3-D tissue and cellular products in-vivo as well as in in-vitro conditions by altering cell growth conditions and using suitable cell isolates from donor tissue and biocompatible scaffold materials. It uses various techniques to restore, repair, maintain, and improve the function of tissue by replacing or restoring damaged tissue to provide improvement in human body functions.

Download Free Sample of Report -

https://www.thebusinessresearchcompany.com/sample.aspx?id=9535&type=smp

Rising Prevalence Of Chronic Diseases And Trauma Emergencies Fueling Tissue Engineering Market Growth
The increase in the prevalence of chronic diseases and trauma emergencies is expected to propel the growth of the tissue engineering market going forward. Chronic diseases refer to clinical conditions that last for 3 months or longer periods and usually can be controlled but not cured, whereas trauma emergencies refer to any physical injury that requires immediate medical attention due to its sudden onset and severity such as traumatic brain injuries. Tissue engineering is widely adopted by healthcare professionals for its various advantage in treating chronic disorders and trauma to avoid end-stage treatment failure including autologous or allograft transplantation, xenotransplantation, and artificial substitutes. For instance, in March 2021, according to the Mary Ann Liebert, Inc. article, a US-based privately held independent publishing company, approximately 2% of the total population in the United States are affected by chronic wounds. Further, in 2020, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency that operates in the prevention and control of disease and injury, around 64,000 occurred in the United States due to traumatic brain injuries and approximately176 deaths every day by TBI. Therefore, the increase in the prevalence of chronic diseases and trauma emergencies is driving the growth of the tissue engineering market.

Competitive Landscape -
Major companies operating in the tissue engineering market report are Medtronic plc, Zimmer Biomet, Allergan plc, Organogenesis Holdings Inc., Integra LifeSciences, Stryker Corporation, DePuy Synthes Companies, Acelity L.P. Inc., B. Braun Melsungen AG, RTI Surgical Inc., AbbVie Inc., Becton Dickinson and Company, Baxter International Inc., Osiris Therapeutics Inc., Organovo Inc., BioTime Inc., Bio Tissue Technologies, Vericel Corporation, Smith and Nephew, Acell Inc., Athersys Inc., Tissue Regenix Group plc, Xeltis AG, Prellis Biologics, Butterfly Network Inc., iThera Medical GmbH, Bit Bio, Be Biopharma Inc., The Takeda Pharmaceutical Company, Frequency Therapeutics, TELA Bio Inc., Orthocell Limited .

Technological Advancements Propelling Tissue Engineering Market Growth
Technological advancement is the key trend that is gaining popularity in the tissue engineering market. Major companies operating in the market are focused on research and development for product innovations that could give better solutions and strengthen their position in the market. For instance, in March 2021, CELLINK, a US-based company operating in tissue engineering introduced its advanced bioprinter that works on 3D bioprinting technology known as BIO MDX Series. 3D bioprinting technology refers to technology that uses bio-inks and living cells to construct natural 3D tissue structures. BIO MDX Series consists of printheads, nanoliter, and picoliter dispensing channels along with robotic integration that provides precision bioprinting for high-throughput fabrication that can be used in advanced cell-based technologies.

Browse Full Report @

https://www.thebusinessresearchcompany.com/report/tissue-engineering-global-market-report

Key Segments -

The tissue engineering market covered in this report is segmented -

1) By Type: Synthetic Scaffold Material, Biologically Derived Scaffold Material, Other Types
2) By Application: Orthopedics And Musculoskeletal, Neurology, Cardiovascular, Skin And Integumentary, Dental, Other Applications,,,,
3) By End-User: Hospitals And Clinics, Ambulatory Facilities

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.